Essen

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines, Beijing Center for Disease Control and Prevention

Conditions

Anti-D AntibodiesRabiesRabies Vaccine AllergyVaccination Adverse Event

Phase 3

A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults

CompletedNCT01680016

Novartis VaccinesRabies

Start: 2012-09-30End: 2013-01-31Updated: 2014-05-20

Phase 4

The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

CompletedNCT01821911

Beijing Center for Disease Control and PreventionAnti-D Antibodies, Rabies Vaccine Allergy, Vaccination Adverse Event

Start: 2012-07-31End: 2014-12-31Updated: 2016-01-20

Related Papers

Immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals: A randomized, parallel-controlled of homologous vaccine with different immune procedure study

Human Vaccines & Immunotherapeutics2024-10-02

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.

2017-01-2518 citations

Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: A randomized open-label study

Human Vaccines & Immunotherapeutics2015-02-0127 citations